Pfizer

By Michael Erman(Reuters) -Pfizer on Friday slashed its full-year revenue forecast by 13% and said it will cut $3.5 billion worth of jobs and expenses due to lower-than-expected sales of its COVID-19 vaccine and treatment.Pfizer earned…

Hospital drug buyers are scrambling to figure out how Hurricane damage At a major Pfizer manufacturing facility, it will affect drug availability across the country at a time of record drug shortages. Healthcare providers Premier Inc.…

iQoncept Buoyed by booming diabetes drug sales, Eli Lilly (New York Stock Exchange: LLY) was the best performer in big pharma or biotech in the first half of 2023, returning dazzling 28%. Coming in at number two, Vertex Pharmaceuticals…

2/2 © Reuters. FILE PHOTO: Vials with a label that says "Vaccine/Coronavirus/COVID-19 ONLY" and a medical syringe in front of the Pfizer logo shown in this illustration taken October 31, 2020. REUTERS/Dado Rovic/File Photo 2/2…